Compliance Statements. The Seller shall deliver, or cause to be delivered, to the Purchaser (i) on or before the thirtieth (30th) day after the one year anniversary of the Closing Date and (ii) on or before each anniversary thereof, an officer’s certificate signed by the Chief Executive Officer, Chief Financial Officer, President, Senior Vice President or any Vice President of the Seller stating that (a) a review of the activities of the Seller during the preceding year and of its performance under this Agreement has been made under such officer’s supervision and (b) to the best of such officer’s knowledge, based on such review, the Seller has fulfilled its obligations under this Agreement throughout such year and has complied in all respects with the Credit and Collection Policies, or, if there has been a default in the fulfillment of any such obligation, specifying each such default known to such officer and the nature and status thereof.
Compliance Statements. 10.1 On the basis of a bilateral agreement between the VA and the CA, the below statement is to be given by the CA (exporting authority) to the VA (importing authority) at the end of the validation project so that the VA may issue the type certificate. “With the determinations of compliance made by the {VA} and summarized in {Letter or document} dated {Date}, the {CA} certifies that the {Specific product type and model} complies with the {VA’s} Certification Basis as identified in {Certification Review Item A-1 or issue paper G-1} dated {Date}.”
10.2 Note that this statement requires the VA to list all compliance findings it has made in a letter or report to the CA.
Compliance Statements. Concurrently with any delivery of financial statements under clause (a) or (b) above, a Compliance Certificate executed by a Financial Officer of the Borrower certifying (i) as to whether a Default or Event of Default has occurred and, if a Default or Event of Default has occurred, specifying the details thereof and any action taken or proposed to be taken with respect thereto and (ii) setting forth reasonably detailed calculations demonstrating compliance (to the extent required) with the covenant contained in Section 6.15;
Compliance Statements. Within thirty (30) days of the end of each fiscal quarter of Lessee, a certificate of Lessee's Chief Financial Officer or other senior officer stating that he or she has reviewed the provisions of the Lease, this Addendum and any other addendum to the Lease then in effect, and that Lessee is not in default in the observance or performance of any of the provisions hereof, or if Lessee shall be so in default, specifying all such defaults and events of which he or she may have knowledge, and setting forth the calculation of compliance or noncompliance with each of the financial covenants set forth in paragraph 4 above.
Compliance Statements. The Oklahoma Blood Institute (OBI) manufacturers Blood and Blood Products under Food and Drug Administration (FDA) license number 0766. Each OBI facility has an FDA assigned Establishment Identification Number (FEIN) and is inspected by the FDA to evaluate Current Good Manufacturing Practices (CGMP) and compliance with relevant sections of 21 CFR 200, 600, 800 and 1200. AABB Blood Bank and Transfusion Services accreditation is maintained by OBI. In accordance with the Social Security Act and 42 CFR Parts 422.156, 422.157 and 422.158 the Health Care Financing Administration has granted AABB deemed status with the Centers for Medicare and Medicaid Services (CMS). Therefore, AABB standards have been found to meet or exceed all relevant CMS requirements for participation. AABB bi-annual assessments evaluate OBI against these standards. Infectious Disease Testing is provided under CLIA number 37D0470358 and Immunohematology Testing is provided under CLIA number 37D2175055 in the headquarters location in Oklahoma City. Immunohematology Testing is also provided under CLIA number 37D0931105 in the Tulsa location, CLIA number 04D2096885 in the Little Rock location, and CLIA number 45D0507042 in the Coffee Memorial Blood Center location. CLIA compliance inspections and renewals are performed bi-annually by the AABB. OBI Laboratories participate in CMS approved proficiency testing programs. AABB Immunohematology Laboratory Accreditation is maintained by the Clinical Laboratories in Oklahoma City, Tulsa, Little Rock, and Coffee Memorial Blood Center. XXX maintains a Quality Plan, Quality Manual, Emergency Preparedness and Disaster Plan, Transfusion Associated Disease Investigation Procedures, Look-Back Procedures (HCV and HIV), and Consignee Notification Procedures for Positive Test Results, Market Recalls and Market Withdrawals for non-conforming blood or blood components. Initial consignee notifications occur in accordance with federal and state statutes and regulations. Specifically within 3 calendar days if the blood collecting establishment supplied blood and blood components collected from a donor who tested negative at the time of donation but tests reactive for evidence of HIV or HCV infection on a later donation or who is determined to be at increased risk for transmitting HIV or HCV infection; within 3 calendar days after the blood collecting establishment supplied blood and blood components collected from an infectious donor, whenever records are available;...
Compliance Statements. As the farm owner, I agree to comply with the Terms and Conditions of the ‘New Zealand Farm Assurance Programme’ (NZFAP) as outlined at xxx.xxxxx.xxx/xxxxx-xxx-xxxxxxxxxx (as may be amended or replaced from time to time) and for the Conformity Assessment Body (CAB) to audit my property in accordance with the NZFAP Standard.
Compliance Statements. A certificate of a Senior Financial Officer of Terra Capital, certifying (A) as to whether the Partnership holds any Permitted Asset which is a financial asset that is in default, (B) the aggregate principal amount of all Demand Loans outstanding on the last day of such Fiscal Quarter, after giving pro forma effect to the Demand Loans and the repayments of Demand Loans made within the 30-day period following the end of such Fiscal Quarter, and (C) that no Terminating Event, Notice Event (other than the Notice Event referred to in clause (a) of the definition thereof set forth in the Appendix attached hereto) or Incipient Event has occurred and is continuing or, if any such Terminating Event, Notice Event or Incipient Event has occurred and is continuing, the actions that the Partnership or any other appropriate Person has taken or proposes to take with respect thereto;
Compliance Statements. 18 Section 6.4 Allocations and Applications of Collections.................. 18 Section 6.5 Termination...................................................18 Section 6.6 Responsibilities of the Originator........................... 18
Compliance Statements. Each Originator shall deliver, or cause to be delivered, to the Purchaser and the Administrator, on or before the date that is 95 days after the end of each Fiscal Year, an officer's certificate signed by the Chief Executive Officer, the President or any Vice President of such Originator, dated as of the last day of the preceding Fiscal Year, stating that (a) a review of the activities of such Originator during the preceding Fiscal Year period and of its performance under this Agreement has been made under such officer's supervision and (b) to the best of such officer's knowledge, based on such review, such Originator has fulfilled its obligations under this Agreement throughout such Fiscal Year and has complied in all respects with the Collection Policy, or, if there has been a default in the fulfillment of any such obligation, specifying each such default known to such officer and the nature and status thereof.
Compliance Statements. Promptly as they are available and in any --------------------- event within (30) days of the end of each fiscal quarter of Borrower a certificate of Borrower's Chief Financial Officer or other senior officer stating that he or she has reviewed the provisions of this Agreement and that Borrower is not in default in the observance or performance of any of the provisions hereof, or if Borrower shall be so in default, specifying all such defaults and events of which he or she may have knowledge and setting forth the calculation of compliance or noncompliance with the financial covenant set forth in Section 7.02.
